Atlas Trials

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Clinical trial NCT07474636 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07474636
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
IgANImmunoglobulin A Nephropathy (IgAN)Glomerular Disease
Start date
2026-03-17
Primary completion
2027-12-10
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.